Israel Englander Adverum Biotechnologies, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.75 - $1.26 $139,208 - $233,869	185,611 Added 165.24%	297,937 $223,000
Q2 2023 Aug 14, 2023	SELL	$0.68 - $1.59 $73,888 - $172,767	-108,659 Reduced 49.17%	112,326 $178,000
Q1 2023 May 15, 2023	SELL	$0.62 - $0.85 $86,871 - $119,098	-140,116 Reduced 38.8%	220,985 $159,000
Q4 2022 Feb 14, 2023	SELL	$0.54 - $10.3 $271,252 - $5.17 Million	-502,320 Reduced 58.18%	361,101 $209,000
Q3 2022 Nov 14, 2022	SELL	$0.96 - $9.68 $168,035 - $1.69 Million	-175,037 Reduced 16.86%	863,421 $820,000
Q2 2022 Aug 15, 2022	BUY	$0.81 - $1.34 $841,150 - $1.39 Million	1,038,458 New	1,038,458 $1.25 Million
Q1 2022 May 16, 2022	SELL	$1.23 - $1.95 $28,443 - $45,093	-23,125 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.74 - $2.4 $1.31 Million - $1.8 Million	-751,727 Reduced 97.02%	23,125 $41,000
Q3 2021 Nov 15, 2021	BUY	$2.08 - $3.6 $1.59 Million - $2.75 Million	763,360 Added 6642.53%	774,852 $1.68 Million
Q2 2021 Aug 16, 2021	BUY	$3.36 - $10.56 $38,613 - $121,355	11,492 New	11,492 $40,000
Q1 2021 May 17, 2021	SELL	$9.26 - $14.36 $240,639 - $373,173	-25,987 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$9.84 - $14.26 $1.5 Million - $2.18 Million	-152,792 Reduced 85.46%	25,987 $282,000
Q3 2020 Nov 16, 2020	SELL	$10.3 - $21.64 $970,033 - $2.04 Million	-94,178 Reduced 34.5%	178,779 $1.84 Million
Q2 2020 Aug 14, 2020	SELL	$8.53 - $25.64 $896,136 - $2.69 Million	-105,057 Reduced 27.79%	272,957 $5.7 Million
Q1 2020 May 14, 2020	BUY	$7.98 - $16.32 $2.85 Million - $5.84 Million	357,649 Added 1756.19%	378,014 $3.69 Million
Q4 2019 Feb 14, 2020	BUY	$5.12 - $12.22 $104,268 - $248,860	20,365 New	20,365 $235,000
Q1 2019 May 14, 2019	SELL	$3.03 - $6.02 $270,324 - $537,080	-89,216 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$2.87 - $5.92 $218,498 - $450,701	-76,132 Reduced 46.04%	89,216 $281,000
Q3 2018 Nov 14, 2018	BUY	$4.5 - $7.6 $45,594 - $77,003	10,132 Added 6.53%	165,348 $1 Million
Q2 2018 Aug 14, 2018	SELL	$5.3 - $6.9 $8.02 Million - $10.4 Million	-1,513,083 Reduced 90.7%	155,216 $823,000
Q1 2018 May 15, 2018	BUY	$3.65 - $7.95 $5.21 Million - $11.3 Million	1,426,877 Added 591.03%	1,668,299 $9.68 Million
Q4 2017 Feb 14, 2018	SELL	$2.85 - $3.95 $21,671 - $30,035	-7,604 Reduced 3.05%	241,422 $845,000
Q3 2017 Nov 14, 2017	BUY	$2.45 - $3.65 $610,113 - $908,944	249,026	249,026 $909,000

Others Institutions Holding ADVM

# of Institutions

Shares Held

524K

Call Options Held

Put Options Held

Versant Venture Management, LLC San Francisco, CA

507K
Shares

$2.4 Million
9.32% of portfolio
Pinz Capital Management, LP New York, NY

15.7K
Shares

$74,418
0.03% of portfolio
American Portfolios Advisors Holbrook, NY

1.15K
Shares

$5,451
0.0% of portfolio

View Full List

About Adverum Biotechnologies, Inc.

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

More about ADVM

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account